Skip to main content

Latest SEC Filings — Page 179

Page 179 · 30 filings scored 7+ · newest 4:07 PM ET · How scores work

Thu, Aug 1330 filings
7ENHAEnhanced Group Inc.Enhanced Group Reports First Public Quarter: $17.7M Revenue, $61.9M Net LossForm 8-K · Current report▼ Negative7PMNProMIS Neurosciences Inc.ProMIS Reports Q2 2026 Results: $53.4M Cash Runway Through 2027, Net Loss Narrows Per ShareForm 8-K · Current report● Neutral8YSSYork Space Systems Inc.York Space Systems Cuts FY26 Revenue Guidance to $375M-$405M Despite Q2 Revenue GrowthForm 8-K · Current report▼ NegativePro7MDRRMedalist Diversified, Inc.Medalist Diversified Reports Q2 Loss, Completes Strategic Shift to DST SponsorshipForm 10-Q · Periodic report● Neutral7ELTXElicio Therapeutics, Inc.Q2 2026 results show a narrower net loss and extended cash runway into Q1 2027Form 8-K · Current report● Neutral7FDMT4D Molecular Therapeutics, Inc.4DMT Reports Q2 2026 Results, Extends Cash Runway to H2 2028Form 8-K · Current report● Neutral8NUWENuwellis, Inc.Nuwellis Reports Q2 Loss, Raises $6.7M Post-Quarter, Names New CEOForm 10-Q · Periodic report▼ NegativePro7CDZICadiz Inc.Cadiz Q2 Revenue Plunges 76% as Losses Widen; Debt Maturities ExtendedForm 10-Q · Periodic report▼ Negative8DLOdLocal LtddLocal Q2 Profit Beats, Raises Guidance, and Secures $150M Credit FacilityForm 6-K · Current report▲ PositivePro8LACLithium Americas Corp.Lithium Americas Closes $150M Convertible Debenture with Yorkville, Details Dilution TermsForm 8-K · Current report▼ NegativePro9FLZHFlash Sports & Media Holdings, Inc.Flash Sports Q2 10-Q: Going Concern Doubt, Material Weaknesses, and $11.3M Net LossForm 10-Q · Periodic report▼ NegativePro7DUKDuke Energy CorporationDuke Energy Closes $2.0B Equity Unit Offering After Full Over-Allotment ExerciseForm 8-K · Current report● Neutral8SOCASolarius Capital Acquisition Corp.Solarius Capital Flags Going Concern Doubt as SPAC Deadline LoomsForm 10-Q · Periodic report▼ NegativePro8NXTSNexentis Technologies Inc.Nexentis Q2 Loss Widens to $11.2M on Warrant Charges; Going Concern ReiteratedForm 10-Q · Periodic report▼ NegativePro7NMAXNewsmax Inc.Newsmax Posts First Quarterly Profit, Reaffirms FY26 Guidance, and Discloses Meta AI PartnershipForm 8-K · Current report▲ Positive8AIROAIRO Group Holdings, Inc.AIRO Q2 Revenue Jumps 76% to $43.2M, but Material Weaknesses PersistForm 10-Q · Periodic report● NeutralPro8SCNXScienture Holdings, Inc.Scienture Holdings Q2 2026: Revenue Ramps, Going Concern Doubt AlleviatedForm 10-Q · Periodic report● NeutralPro8SPEGSilver Pegasus Acquisition Corp.SPAC Reiterates Going Concern Doubt with $159,863 Cash and January 2027 Liquidation DeadlineForm 10-Q · Periodic report▼ NegativePro9ARAIArrive AI Inc.Arrive AI 10-Q: Going Concern, 41% Potential Dilution, and Material WeaknessForm 10-Q · Periodic report▼ NegativePro7EIKNEikon Therapeutics, Inc.Eikon Therapeutics Reports Q2 2026 Results and Clinical UpdatesForm 8-K · Current report▲ Positive7QNTMQuantum Biopharma Ltd.Quantum BioPharma Posts Q2 2026 Loss of $3.1M; GBB Trial Set for Aug 24Form 6-K · Current report▼ Negative8BRRProCap Financial, Inc.Bitcoin Slump Drives $65M Q2 Loss for ProCapForm 10-Q · Periodic report▼ NegativePro8ELTPElite Pharmaceuticals, Inc.Elite Pharmaceuticals Q1 FY2027: Revenue Falls 19.5%, Material Weaknesses DisclosedForm 10-Q · Periodic report▼ NegativePro8AMPGAmpliTech Group, Inc.AmpliTech Q2 Loss Widens 74% as Costs Surge; Material Weaknesses PersistForm 10-Q · Periodic report▼ NegativePro8MYSZMy Size, Inc.My Size Q2 Loss Widens 289% as Cash Drops to $453K; Going Concern and Nasdaq MVLS Deficiency FlaggedForm 10-Q · Periodic report▼ NegativePro7DMRCDigimarc CorpDigimarc Q2 Revenue Beats, But ARR Slides 27% and Cash Drops to $8.8MForm 8-K · Current report▼ Negative7SBFMSunshine Biopharma Inc.Sunshine Biopharma's Q2 Loss Deepens as ATM Sales Add $1.7M and Warrant Overhang ExpandsForm 10-Q · Periodic report▼ Negative8SPRYARS Pharmaceuticals, Inc.ARS Pharmaceuticals Q2: Revenue Doubles, But Losses Widen and Legal Battles MountForm 10-Q · Periodic report▼ NegativePro8VUZIVuzix CorpVuzix Q2 Revenue Falls 14%, Going Concern Doubt Raised but AlleviatedForm 10-Q · Periodic report▼ NegativePro9APTNADAPTIN BIO, INC.Adaptin Bio Flags Going Concern, Material Weaknesses in Q2 10-QForm 10-Q · Periodic report▼ NegativePro
How Wiseek picks and scores these

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.